Published in Virology on May 10, 2001
The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction. J Virol (2002) 1.31
Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob Agents Chemother (2004) 1.11
The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Antimicrob Agents Chemother (2005) 1.07
The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals. Virology (2013) 0.89
The C-terminal 88 amino acids of the Sendai virus P protein have multiple functions separable by mutation. J Virol (2002) 0.81
Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (1994) 5.49
Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol (2000) 4.10
The Sendai virus nucleocapsid exists in at least four different helical states. J Virol (1989) 2.30
Properties of incomplete Sendai virions and subgenomic viral RNAs. Virology (1970) 2.26
Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A viruses. Virology (1980) 2.11
Sendai virus replication: an ultrastructural comparison of productive and abortive infections in avian cells. J Gen Virol (1970) 1.98
Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology (1994) 1.91
Ribonucleic acid transcriptases in Sendai Virions and infected cells. J Virol (1971) 1.84
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67
Role of matrix and fusion proteins in budding of Sendai virus. J Virol (2001) 1.58
Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology (1987) 1.52
Receptor specificities of human respiroviruses. J Virol (2001) 1.48
Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins. J Virol (1974) 1.45
Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J Virol (1998) 1.43
A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology (1975) 1.43
The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology (1990) 1.39
Isolation and characterization of Sendai virus temperature-sensitive mutants. J Virol (1974) 1.38
Complementary RNAs in paramyxovirions and paramyxovirus-infected cells. Nature (1970) 1.38
On the genesis of incomplete Sendai virions. Virology (1970) 1.35
Identification of transcriptive and replicative intermediates in Sendai virus-infected cells. Virology (1972) 1.34
Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J Virol (2001) 1.30
Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology (2000) 1.29
Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine (1997) 1.28
The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology (1987) 1.28
An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proc Natl Acad Sci U S A (1985) 1.26
The M2 ectodomain is important for its incorporation into influenza A virions. J Virol (1998) 1.25
Separate domains of Sendai virus P protein are required for binding to viral nucleocapsids. Virology (1990) 1.24
Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides. Virus Res (1986) 1.24
Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants. Virology (1987) 1.23
The HN glycoprotein of Sendai virus: analysis of site(s) involved in hemagglutinating and neuraminidase activities. Virology (1981) 1.21
Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol (1990) 1.21
Structural and functional analysis of Sendai virus nucleocapsid protein NP with monoclonal antibodies. Virology (1984) 1.21
Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection. Virology (1994) 1.17
Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology (1986) 1.11
Regulatory events in the synthesis of Sendai virus polypeptides and their assembly into virions. Virology (1976) 1.11
Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol (1996) 1.10
Monoclonal antibodies to the P protein of Sendai virus define its structure and role in transcription. Virology (1985) 1.09
The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants. J Gen Virol (1991) 1.09
Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT). Arch Otorhinolaryngol (1984) 1.08
Antibodies to paramyxovirus nucleoproteins define regions important for immunogenicity and nucleocapsid assembly. Virology (1993) 1.07
Functions of Sendai virus nucleocapsid polypeptides: enzymatic activities in nucleocapsids following cleavage of polypeptide P by Staphylococcus aureus protease V8. Virology (1981) 1.07
Homologous interference by incomplete Sendai virus particles: changes in virus-specific ribonucleic acid synthesis. J Virol (1971) 1.05
Sequence characterization and expression of the matrix protein gene of human parainfluenza virus type 1. Virology (1992) 1.05
Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain. Virology (1991) 1.05
Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins. J Virol (1986) 1.04
The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogeneous. Virology (1992) 1.03
Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. J Infect Dis (1994) 1.03
A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter (1998) 1.02
Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J Natl Cancer Inst (1985) 1.01
Measles virus ribonucleic acid and protein synthesis: effects of 6-azauridine and cycloheximide on viral replication. J Virol (1973) 1.01
Charge heterogeneity in polypeptides of negative strand RNA viruses. Virology (1978) 0.99
Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol (1998) 0.99
Mapping of antigenic domains of Sendai virus nucleocapsid protein expressed in Escherichia coli. J Virol (1988) 0.99
Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood (2000) 0.99
Elevated expression of the human parainfluenza virus type 1 F gene downregulates HN expression. Virology (1997) 0.98
Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl (1996) 0.97
Fusion of a Sendai mutant deficient in HN protein (ts271) with cardiolipin liposomes. Virology (1988) 0.97
Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Virology (1994) 0.97
Synthesis of message and genome RNAs in vitro by Sendai virus-infected cell nucleocapsids. J Gen Virol (1982) 0.95
Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res (1992) 0.95
Linked transcripts of the genes for leader and N message are synthesized in vitro by vesicular stomatitis virus. Biochem Biophys Res Commun (1982) 0.93
A 1-h topical therapy for the treatment of Helicobacter pylori infection. Am J Gastroenterol (1995) 0.93
Synthesis of Sendai virus polypeptides by a cell-free extract from wheat germ. J Gen Virol (1976) 0.93
A single amino acid changes enhances the fusion promotion activity of human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Virology (1995) 0.93
Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1. Virology (1994) 0.93
A plasmid that improves the efficiency of foreign gene expression by intracellular T7 RNA polymerase. Genet Anal Tech Appl (1992) 0.92
Crystallization of Sendai virus HN protein complexed with monoclonal antibody Fab fragments. Virology (1989) 0.92
Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia (1989) 0.91
Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties. J Natl Cancer Inst (1986) 0.90
Expression of Sendai virus defective-interfering genomes with internal deletions. Virology (1985) 0.90
Relationship between Helicobacter pylori and atrophic gastritis. Eur J Gastroenterol Hepatol (1994) 0.89
Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Cancer Res (1986) 0.89
Molecular cloning and expression of human parainfluenza virus type 1 L gene. Virus Res (2000) 0.89
Synaptic junctions in the cat spinal ganglion. Brain Res (1981) 0.88
Antibody response in children to antigen sites on human PIV-3 HN: correlation with known epitopes mapped by monoclonal antibodies. Vaccine (1990) 0.88
Topography of a flexible ribonucleoprotein helix: protein-protein contacts in Sendai virus nucleocapsids. J Virol (1979) 0.88
Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. J Gen Virol (1989) 0.87
Neuraminidase inhibitors as antiviral agents. Curr Drug Targets Infect Disord (2005) 0.87
Metabolic basis for differential glutamine requirements of human leukemia cell lines. J Cell Physiol (1990) 0.85
[Experimental studies on viral etiology of Epstein-Barr (EBV) in nasopharyngeal carcinoma (NPC):establishment of EBV infection on human epithelial derived from nasopharyngeal tissue (author's transl)]. Nihon Jibiinkoka Gakkai Kaiho (1979) 0.85
The role of haemagglutinin-neuraminidase glycoprotein cell surface expression in the survival of Sendai virus-infected BHK-21 cells. J Gen Virol (1985) 0.85
Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Ann Otol Rhinol Laryngol (1984) 0.84
VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase death. Exp Cell Res (1989) 0.84
Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1. J Virol (1992) 0.84
Gene mapping of an Epstein-Barr virus isolate obtained from a nasopharyngeal carcinoma. Intervirology (1989) 0.84
Biosynthesis of 1,2-dieicosapentaenoyl-sn-glycero-3-phosphocholine in Caenorhabditis elegans. Eur J Biochem (1999) 0.83
Localization of P protein binding sites on the Sendai virus nucleocapsid. J Gen Virol (1990) 0.83
Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants. J Gen Virol (1991) 0.83
Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus. Vaccine (2012) 0.83